News 2019-09-24
Porton will attend 2019 Pharma Integrates
As one of the Silver Sponsors of 2019 Pharma Integrates, Peter Lyford, Business Development Director (UK & Ireland) of Porton Pharma Solutions will join the panel discussion during those two days.
2019 Pharma Integrates will take place from Nov.18 to 19 in London. Kindly follow us!
https://www.linkedin.com/company/life-science-integrates/
Others
More
News 2025-07-31
Porton Participates in Publishing an OPRD Paper, Demonstrating Strength in Drug Synthesis Technology
Metal catalytic and DoE technologies for the optimization of CT1812 synthesis routes

News 2025-07-31
NMPA Approves Jike Shu (Sebaloxavir Marboxil Tablets) for the Treatment of Uncomplicated Influenza in Adults
Self-developed novel PA endonuclease inhibitor anti-influenza drug Jike Shu (Sebaloxavir Marboxil Tablets) has officially received marketing approval from China's National Medical Products Administration (NMPA) for the treatment of uncomplicated influenza in adults.